BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Combined Know-How For Cell-type Specific Expression Profiling - Axaron Bioscience AG Enters Into A Cooperation Agreement With The RZPD German Resource Center for Genome Research


10/19/2005 5:10:27 PM

Heidelberg, Germany, March 8, 2004 - The RZPD German Resource Center for Genome Research, Berlin, has entered into a cooperation agreement with the Heidelberg based biotechnology company Axaron Bioscience AG. The aim of this cooperation is to combine Axaron's Axaminer™ cell-type specific expression profiling technology with RZPD's services based on Affymetrix GeneChip® expression arrays. Customers will benefit from the integrated and cost effective service capabilities of both parties. Axaron and RZPD aim to attract new customers in sectors of drug discovery and development companies by co-marketing their services in future.

RZPD is an authorized Affymetrix partner, which provides Affymetrix services to customers throughout Europe. Axaron provides the Axaminer™ service for gene expression profiling of specific cell types from complex tissues and organs. The Axaminer™ platform is comprised of four integrated modules: specific cell labeling, automated cell isolation using laser microdissection, isolation and amplification of tiny amounts of RNA, as well as subsequent expression profiling. Axaron offers its Axaminer™ technology as a customer tailored solution, which enables unique cell-type specific insights to molecular processes hitherto not possible with existing analytical methods.

(206 words)

Media Contact:
Alexander Pschera
Axaron Bioscience AG
Im Neuenheimer Feld 515
D-69120 Heidelberg, Germany
Tel.: +49 (0)6221 454-705
Fax: +49 (0)6221 454-776
Email: Alexander.pschera@axaron.com
www.axaron.com

Axaron Bioscience AG is a Heidelberg-based biotechnology company which pioneers innovative therapies for neurodegenerative diseases such as stroke or Parkinson's. The company capitalizes on its uniquely integrated functional genomics and proteomics technology platform and its world-leading network of expert partners in the CNS field. Axaminer™ is based on Axaron's proprietary technology and enables gene expression profiling at a cellular level. The Axaminer™ technology comprises four integrated modules offered as a full service or tailor-made solution to pharmaceutical companies. For further information please visit www.axaron.com

RZPD - German Resource Center for Genome Research (Deutsches Ressourcenzentrum für Genomforschung), Berlin, is the largest and most modern service centre for genomics and proteomics research in Europe. Based on one of the largest clone collections worldwide, it provides high quality research material, high throughput technology and automation solutions for academic institutions as well as for industry. The RZPD's portfolio includes clones of genomic and cDNA libraries, expression clones with full open reading frames, siRNA resources, high-density colony, DNA, and protein arrays, custom microarrays, expression profiling, Affymetrix service, high-throughput PCR amplification, and cDNA library generation. For a full listing please refer to www.rzpd.de. The RZPD is certified to comply with the quality standards ISO 9001:2000.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES